Article
Induced pluripotent stem cells provide mega insights into kidney disease.
Kidney international - 1 Jul 2020
Luciani Alessandro, Freedman Benjamin S
Abstract excerpt
Rare mutations in the LRP2 gene encoding for the endocytic receptor megalin cause developmental abnormalities and kidney disease. However, the mechanisms governing the dysfunction of mutant megalin remain unclear. A new study utilizing patient-derived induced pluripotent stem cells is now putting the endolysosomal system into the spotlight, as it is proposed to play a central role in the regulation of megalin in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
